Prospective randomized trial comparing efficacy and safety of intravenous and intra-articular tranexamic acid in total knee arthroplasty
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Total knee arthroplasty (TKA) is associated with significant perioperative blood loss and postoperative allogenic blood transfusion. Tranexamic acid (TXA) reversibly blocks lysine binding sites on plasminogen molecules and inhibits plasmin formation. Comparisons of the efficacy and safety of intra-articular and intravenous TXA in primary TKA have not previously been reported.A prospective randomized trial was conducted in 150 patients who underwent TKA, and these patients were randomized into three groups. Patients in Group A were injected by intra-articular TXA according to body weight (20 mg/kg). Patients in Group B received a standard dose of intra-articular TXA (2000 mg), and those in Group C were infused with TXA according to body weight (20 mg/kg) before tourniquet deflation and again 3 h later. Baseline characteristics and data collected at blood transfusion were compared. Differences among four time points (baseline, day 0, day 2, and day 5) were carried out using ANOVA. The hemoglobin levels at postoperative day 5 were 10.6 g/dL for Group A, 10.6 g/dL for Group B, and 10.7 g/dL for Group C. The drain output was 399 ml for Group A, 314 ml for Group B, and 305 ml for Group C ( p = 0.03). Group C had significantly less drain output than Group A after post hoc comparisons ( p = 0.05), whereas no significant difference was observed between Group A and B ( p = 0.09) or between Group B and C. The weight-adjusted dose of TXA administered intravenously significantly reduced the drain output but not the total blood loss when compared with the weight-adjusted dose of TXA administered intra-articularly. No significant difference was observed in the other parameters among the three groups. The Joint CUHK-NTEC CREC, CRE-2013.644-T . Registered 1 March 2014.
Abstract
Total knee arthroplasty (TKA) is associated with significant perioperative blood loss and postoperative allogenic blood transfusion. Tranexamic acid (TXA) reversibly blocks lysine binding sites on plasminogen molecules and inhibits plasmin formation. Comparisons of the efficacy and safety of intra-articular and intravenous TXA in primary TKA have not previously been reported.A prospective randomized trial was conducted in 150 patients who underwent TKA, and these patients were randomized into three groups. Patients in Group A were injected by intra-articular TXA according to body weight (20 mg/kg). Patients in Group B received a standard dose of intra-articular TXA (2000 mg), and those in Group C were infused with TXA according to body weight (20 mg/kg) before tourniquet deflation and again 3 h later. Baseline characteristics and data collected at blood transfusion were compared. Differences among four time points (baseline, day 0, day 2, and day 5) were carried out using ANOVA. The hemoglobin levels at postoperative day 5 were 10.6 g/dL for Group A, 10.6 g/dL for Group B, and 10.7 g/dL for Group C. The drain output was 399 ml for Group A, 314 ml for Group B, and 305 ml for Group C ( p = 0.03). Group C had significantly less drain output than Group A after post hoc comparisons ( p = 0.05), whereas no significant difference was observed between Group A and B ( p = 0.09) or between Group B and C. The weight-adjusted dose of TXA administered intravenously significantly reduced the drain output but not the total blood loss when compared with the weight-adjusted dose of TXA administered intra-articularly. No significant difference was observed in the other parameters among the three groups. The Joint CUHK-NTEC CREC, CRE-2013.644-T . Registered 1 March 2014.
참고문헌 (17)
- Spahn DR, "Anemia and patient blood management in hip and knee surgery : a systematic review of the literature", Anesthesiology, 113(2), pp.482~495 (2010)[DOI]
- Seo JG, "The comparative efficacies of intra-articular and IV tranexamic acid for reducing blood loss during total knee arthroplasty", Knee Surg Sports Traumatol Arthrosc, 21(8), pp.1869~1874 (2013)[DOI]
- Goyal N, "Intravenous vs intra-articular tranexamic acid in total knee arthroplasty : a randomized, double-blind trial", J Arthroplasty, 32(1), pp.28~32 (2017)[DOI]
- Yang ZG, "Effectiveness and safety of tranexamic acid in reducing blood loss in total knee arthroplasty : a meta-analysis", J Bone Joint Surg Am, 94(13), pp.1153~1159 (2012)[DOI]
- Wong J, "Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty : a randomized, controlled trial", J Bone Joint Surg Am, 92(15), pp.2503~2513 (2010)[DOI]
- Iijima T, "The maintenance and monitoring of perioperative blood volume", Perioper Med, 2(1), pp.9~ (2013)[DOI]
- Nadler SB, "Prediction of blood volume in normal human adults", Surgery, 51(2), pp.224~232 (1962)
- Johansson T, "Tranexamic acid in total hip arthroplasty saves blood and money : a randomized, double-blind study in 100 patients", Acta Orthop, 76(3), pp.314~319 (2005)
- Panteli M, "Topical tranexamic acid in total knee replacement : a systematic review and metaanalysis", Knee, 20(5), pp.300~309 (2013)[DOI]
- Kim TK, "Practical issues for the use of tranexamic acid in total knee arthroplasty : a systematic review", Knee Surg Sports Traumatol Arthrosc, 22(8), pp.1849~1858 (2014)[DOI]
- Tanaka N, "Timing of the administration of tranexamic acid for maximum reduction in blood loss in arthroplasty of the knee", J Bone Joint Surg Br, 83(5), pp.702~705 (2001)[DOI]
- Sano M, "Absorption and excretion of tranexamic acid following intravenous, intramuscular and oral administrations in healthy volunteers", Rinsho yakuri, 1976, pp.7(4), 375~382
- Benoni G, "Application of pharmacokinetic data from healthy volunteers for the prediction of plasma concentrations of tranexamic acid in surgical patients", Clin Drug Investig, 10(5), pp.280~287 (1995)[DOI]
- Nilsson IM, "Clinical pharmacology of aminocaproic and tranexamic acids", J Clin Pathol Suppl. (Royal College of Pathologists), 14, pp.41~47 (1980)
- Kagoma YK, "Use of antifibrinolytic therapy to reduce transfusion in patients undergoing orthopedic surgery : a systematic review of randomized trials", Thromb Res, 123(5), pp.687~696 (2009)[DOI]
- Ralley FE, "One intraoperative dose of tranexamic acid for patients having primary hip or knee arthroplasty", Clin Orthop Relat Res, 468(7), pp.1905~1911 (2010)[DOI]
- Iwai T, "Repeatdose intravenous tranexamic acid further decreases blood loss in total knee arthroplasty", Int Orthop, 37(3), pp.441~445 (2013)[DOI]